Key result
Prescription omega-3 fatty acids substantially reduce triglycerides and VLDL in severe hypertriglyceridemia.
Why the study?
Do omega-3 fatty acid prescription formulations reduce triglyceride levels in adults with severe hypertriglyceridemia?
Population
Adults with severe hypertriglyceridemia (triglycerides ≥ 500 mg/dL)
Design
Review
Authors
Loading...
Supports prescription omega-3s for triglyceride lowering in severe hypertriglyceridemia; leaves open cardiovascular outcome effects.
Do omega-3 fatty acid prescription formulations reduce triglyceride levels in adults with severe hypertriglyceridemia?
Omega-3 fatty acid prescription formulations are an effective and well-tolerated treatment option for reducing triglycerides in adults with severe hypertriglyceridemia.
Backes et al. (2016) conducted a review in Hypertriglyceridemia. Omega-3 fatty acids vs. Placebo was evaluated on Triglyceride levels. Prescription formulations of omega-3 fatty acids substantially reduce triglyceride and very-low-density lipoprotein levels in patients with severe hypertriglyceridemia.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: